Harvard Bioscience (HBIO) Operating Income (2010 - 2026)
Harvard Bioscience (HBIO) posted quarterly Operating Income of -$1.2 million for Q1 2026, up 97.64% year-over-year from -$594020.4 in Q1 2025, and down 168.65% quarter-over-quarter from $1.7 million in Q4 2025.
Harvard Bioscience (HBIO) Operating Income (2010 - 2026) Analysis & Trends
Harvard Bioscience (HBIO) has reported Operating Income for 17 consecutive years, with -$1.2 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Operating Income rose 97.64% year-over-year to -$1.2 million; the TTM figure through Mar 2026 stood at -$86000.0 (up 99.84% YoY), while the FY2025 annual figure was -$48.6 million, down 682.16% from the prior year.
- Operating Income retreated to -$1.2 million in Q1 2026 per HBIO's latest filing, from $1.7 million in the prior quarter.
- Across five years, Operating Income topped out at $4.0 million in Q2 2022 and bottomed at -$49.7 million in Q1 2025.
- Historically, Operating Income has averaged -$3.6 million across 5 years, with a median of -$819000.0 in 2025.
- Annual changes were most pronounced in 2022 — Operating Income plunged 2708.37% — and 2025, when it soared 15445.45%.
- Harvard Bioscience's Operating Income stood at -$457000.0 in 2022, then soared by 161.71% to $282000.0 in 2023, then tumbled by 96.1% to $11000.0 in 2024, then jumped by 15445.45% to $1.7 million in 2025, then tumbled by 168.65% to -$1.2 million in 2026.
- Business Quant data shows HBIO's Operating Income at -$1.2 million in Q1 2026, $1.7 million in Q4 2025, and $197000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 971.90 Mn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 663.00 Mn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | 11.00 Mn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 448.71 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 395.00 Mn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 179.10 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 181.00 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | -31.00 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 217.00 Mn |
| 10 | Harvard Bioscience | 33.45 Mn | 26.94 Mn | 12.63 Mn | -978,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -978,000.00 |
| Mar 31, 2026 | -1.17 Mn |
| Dec 31, 2025 | 1.71 Mn |
| Sep 30, 2025 | 197,000.00 |
| Jun 30, 2025 | -819,000.00 |
| Mar 31, 2025 | -49.67 Mn |
| Dec 31, 2024 | 11,000.00 |
| Sep 30, 2024 | -1.87 Mn |
| Jun 30, 2024 | -2.07 Mn |
| Mar 31, 2024 | -2.28 Mn |
| Dec 31, 2023 | 282,000.00 |
| Sep 30, 2023 | -933,000.00 |
| Jun 30, 2023 | 796,000.00 |
| Mar 31, 2023 | 1.75 Mn |
| Dec 31, 2022 | -457,000.00 |
| Sep 30, 2022 | -3.76 Mn |
| Jun 30, 2022 | 4.00 Mn |
| Mar 31, 2022 | -6.71 Mn |
| Dec 31, 2021 | 1.70 Mn |
| Sep 30, 2021 | 548,000.00 |